Targeting of hyperactivated mTOR signaling in high-risk acute lymphoblastic leukemia in a pre-clinical model

Despite increasingly successful treatment of pediatric ALL, up to 20% of patients encounter relapse. By current biomarkers, the majority of relapse patients is initially not identified indicating the need for prognostic and therapeutic targets reflecting leukemia biology. We previously described tha...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Hasan, Md. Nabiul, Queudeville, Manon, Trentin, Luca, Eckhoff, Sarah Mirjam, Bronzini, Ilaria, Palmi, Chiara, Barth, Thomas, Cazzaniga, Giovanni, te Kronnie, Geertruy, Debatin, Klaus-Michael, Meyer, Lüder Hinrich
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2014
Assuntos:
Priority Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4359301/
https://ncbi.nlm.nih.gov/pubmed/25682198
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados